Choroidal Morphology Changes After Aflibercept Therapy in Pachychoroid Neovasculopathy
Status:
Not yet recruiting
Trial end date:
2023-12-26
Target enrollment:
Participant gender:
Summary
In the present study, investigators attempt to evaluate the short-term, detailed changes in
choroidal morphology after three monthly injections of aflibercept in pachychoroid
neovasculopathy. The association between these changes and clinical outcomes will be
additionally investigated. The primary purpose of this study is to provide reference data
regarding the aflibercept-related morphologic changes that implicate structural and
functional choroidal alteration, and hence its clinical implications.
Phase:
Phase 4
Details
Lead Sponsor:
Kim's Eye Hospital
Collaborators:
HanGil Eye Hospital Nune Eye Hospital, Seoul, Korea